Lactose (India) is an API manufacturer based in India. It holds one active US drug master file and one valid CEP. Its filings concentrate with NAFDAC (NG), UZPHARM (UZ) and MINSA (CR). Its GMP standing is certified by CDSCO (India), NAFDAC (NG) and EAEU_EEC. Customs aggregates show $3.4M of exports covering 46 molecules to 9 destinations in 2025.
| Site | FDA FEI |
|---|---|
| Vadodara, India | 3014659521 |
| Mumbai, India | Not on file |
| e poicha rania tal savli poicha vadodara, India | Not on file |
| a rania tal savlipoichavadoda ra 391 780, India | Not on file |
| RICT -VADODARA, Nigeria | Not on file |
| Molecule | Regulators | Docs |
|---|---|---|
| Lactulose | EDQM, US FDA | 2 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| NAFDAC (NG) | 3 | 2 |
| UZPHARM (UZ) | 1 | None |
| MINSA (CR) | 1 | None |
| CDSCO (India) | None | 3 |
| EAEU_EEC | None | 1 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $331K | 3 |
| 2025 | Not reported | $3.4M | 9 |
| 2024 | Not reported | $1.2M | 7 |
| 2023 | Not reported | $1.5M | 7 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.
Choose your molecules and target markets. Lactose (India) comes back tiered against every other supplier able to file there.
Start for freeRanked by shared active ingredients where we have them, otherwise by country and comparable credentials.